Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | -0.23% | 242.74 | 1.5% | $877.10m | |
| MRNA | Moderna, Inc. | 4.78% | 149.68 | 0.0% | $809.23m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.31% | 282.66 | 1.9% | $481.31m | |
| GILD | Gilead Sciences, Inc. | -0.29% | 61.63 | 1.0% | $474.01m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.37% | 588.92 | 2.6% | $469.90m | |
| NVAX | Novavax, Inc. | 10.62% | 56.89 | 75.7% | $440.83m | |
| ILMN | Illumina, Inc. | 1.64% | 187.38 | 3.3% | $341.36m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -2.58% | 3.78 | 0.7% | $264.24m | |
| BIIB | Biogen, Inc. | 1.24% | 206.47 | 1.8% | $241.02m | |
| BNTX | BioNTech SE | 4.52% | 155.84 | 0.0% | $195.61m | |
| CRSP | CRISPR Therapeutics AG | 2.73% | 62.43 | 0.6% | $164.46m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.45% | 83.24 | 4.2% | $116.70m | |
| EXAS | EXACT Sciences Corp. | 2.54% | 40.39 | 17.7% | $93.24m | |
| IOVA | Iovance Biotherapeutics, Inc. | 2.63% | 11.33 | 0.0% | $90.42m | |
| TECH | Bio-Techne Corp. | 0.42% | 348.09 | 4.5% | $89.99m |
Company Profile
Liminal BioSciences, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using drug discovery platform and a data driven approach. The firm has business operations in Canada and the United Kingdom. Its small molecule product candidate, fezagepras, has completed a Phase 1 multi-ascending dose clinical trial and anticipate conducting a comparative Phase 1a single ascending dose clinical trial to provide comparative data to support development plan. The company was founded on October 14, 1994 and is headquartered in Laval, Canada.